Skip to main content
OpenTrials

Clinical trial condition

Alphavirus Infections

Explore clinical trials studying Alphavirus Infections. Study availability and eligibility vary by location and protocol.

77 public trials 7 recruiting studies
Refine in advanced search Browse all conditions

Alphavirus Infections trial results

Completed

Safety and Immunogenicity of CHIKV VLP Vaccine PXVX0317 in Adults ≥65 Years

NCT05349617

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Suncoast Research Associates, LLC Miami, Florida, United States
  • Panax Clinical Research Miami Lakes, Florida, United States
  • Global Clinical Research Professionals (GCP) St. Petersburg, Florida, United States
  • AMR Kansas City Kansas City, Missouri, United States
View Trial Details
Completed

A Phase 3 Trial of the VLP-Based Chikungunya Vaccine PXVX0317 (CHIKV VLP Vaccine)

NCT05072080

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • Optimal Research, LLC Huntsville, Alabama, United States
  • Alliance for Multispecialty Research - Mobile Mobile, Alabama, United States
  • Alliance for Multispecialty Research, LLC Tempe, Arizona, United States
  • Velocity Clinical Research, Banning Banning, California, United States
View all 47 locations
View Trial Details
Completed

Study to Demonstrate Consistency of Three Lots of a Live-attenuated Chikungunya Virus Vaccine Candidate in Healthy Adults

NCT04786444

Conditions
Alphavirus Infections, Arbovirus Infections, Chikungunya Fever, +7 more
Locations
  • AMR Miami Coral Gables, Florida, United States
  • AMR Fort Myers Fort Myers, Florida, United States
  • St. Johns Center for Clinical Research Ponte Vedra, Florida, United States
  • AMR Wichita West Wichita, Kansas, United States
View Trial Details

Related conditions